Bupropion vs Tildrakizumab

## Bupropion vs Tildrakizumab: Overview

This comparison examines the pharmacological differences between **Bupropion** and **Tildrakizumab**.

## Mechanism of Action

**Bupropion**: Norepinephrine-dopamine reuptake inhibitor (NDRI).

## Pharmacokinetics

**Half-life**: Bupropion — 21 hours; Tildrakizumab — N/A.

## Chemical Properties

**Molecular Formula**: Bupropion — C13H18ClNO; Tildrakizumab — N/A.

**Molecular Weight**: Bupropion — 239.7420 g/mol; Tildrakizumab — N/A.

**Type**: Bupropion — Small molecule; Tildrakizumab — Antibody.